# Clinical and Translational Science Award

> **NIH NIH UL1** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2021 · $10,120,986

## Abstract

Contact PD/PI: Reilly, Muredach P
OVERALL: PROJECT SUMMARY/ABSTRACT
Our mission is to improve the health of our patients and communities both locally and nationally through
innovations in clinical and translational research. Our strategic vision is to catalyze all phases of clinical and
translational science (T0-T4), synergize with our partners and stakeholders, and integrate activities within our
hub and across the national Clinical and Translational Science Award (CTSA) Program. To achieve this vision,
we will build on our strong established track-record (e.g., in precision medicine), our plans to tackle important
public-health challenges (e.g., COVID-19 pandemic, the opioid crisis) and to address critical barriers (e.g.,
innovation in use of electronic health records for research, clinical trial designs) as we embrace the CTSA
Program priorities designated in PAR-18-940. Our vision is to transform the health and wellbeing of our
communities in New York City, the nation and the world. To achieve this, we deploy our programs and resources
to develop, demonstrate and disseminate innovations in
clinical and translational science
across the full
translational spectrum.
As a comprehensive CTSA, we offer a broad array of support for trainees, scholars and
investigators across our entire hub which includes Columbia University, the Columbia University Irving Medical
Center, the New York Psychiatric Institute, and New York Presbyterian Hospital. At the same time, we move
flexibly and deeply to address critical scientific or institutional opportunities as well as major public health needs
and gaps. We achieve success by approaching our goals at multiple levels: a) Ongoing strategic planning
including an annual retreat to review operations and identify gaps, needs and opportunities; b) Monthly cross-
cutting “Theme” meetings to enable collaborative problem-solving in addressing gaps and opportunities; c) An
innovative Evaluation and Continuous Improvement strategy using participatory management to integrate
evaluation into program planning and execution; and d) A highly successful, innovative interdisciplinary training
and workforce development program built on a foundation of team science. Central to our efforts to improve
health and wellbeing at personal, community and national levels is our emphasis on strategic collaboration and
dissemination. Thus, we seek to continuously create and refine innovations for an integrated research- and user-
friendly translational research environment at our hub by: Harnessing partnerships across our entire hub;
Transforming collaborations with our local communities, the campus health system and across New York State;
And by accelerating bidirectional dissemination of innovative practices and learnings through collaborations with
the CTSA Program network and beyond.
Project Summary/Abstract Page 221
Contact PD/PI: Reilly, Muredach P
Narrative
The Clinical and Translational Science Award (CTSA) allows Columbia University...

## Key facts

- **NIH application ID:** 10349079
- **Project number:** 2UL1TR001873-06
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Muredach P Reilly
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $10,120,986
- **Award type:** 2
- **Project period:** 2016-07-01 → 2026-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10349079

## Citation

> US National Institutes of Health, RePORTER application 10349079, Clinical and Translational Science Award (2UL1TR001873-06). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10349079. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*